Road2HardCoreIron
Bodybuilding Discussion => Anabolic Steroids News => Topic started by: Big Chicken on March 13, 2022, 10:46:21 am
-
those who do not want to inject testosterone Andriol Testo caps have been updated keep in mind there are on going and many studies. You no longer have to keep them in the fridge. This drug can not be counterfeit by anyone. Yes you still will have to take 5-6 caps spread out twice a day. The new improve is much better absorb. Great gor bridging or break in between cycles as well. It s much like primo tabs it is not 17 alk. Therefore very easy on liver. I might Spencer someone to cycle this with a primo cycle to see if Andriol androgen is enough for primobolan to cling to its androgen receptors. To allow primo to Do its job. I have not seen any studies in the to. But I know how important it is to have a test base when running primo.
Abstract
Objective: The objective of this study was to document the efficacy and tolerability of the new formulation of Andriol Testocaps in the treatment of late-onset hypogonadism in a clinical practice setting.
Methods: The primary inclusion criterion was symptomatic testosterone deficiency, as confirmed by laboratory testing (morning total testosterone <12 nmol/L) on two separate occasions. The study was performed in 43 centres in Austria and a dosage of oral testosterone undecanoate of 2 x 80 mg/day was used for three months. The ADAM questionnaire, the AMS scale and the SF-36 questionnaire were administered by the patients and specific questions were asked to the prescribers.
Results: A total of 189 patient report forms and 185 doctor report forms were completed. The average age of the participants was 54.7 +/- 12.3 years and average treatment duration was 13.9 +/- 2.2 weeks. Serum testosterone level increased by more than 50% from 8.7 +/- 4.3 nmol/L to 13.2 +/- 6.7 nmol/L (p < 0.001). Treatment improved symptoms on the ADAM and AMS scales, whereas no changes were observed on the SF-36. There were no significant effects on serum PSA levels.
Conclusion: Short-term treatment with oral testosterone undecanoate in a clinical practice setting improved late-onset hypogonadism symptoms in aging men with low testosterone levels.
Last edited: A moment ago